TIGIT and HIV infectious disease: These findings suggest that TIGIT inhibition of CD8+ T and NK cell surveillance against HIV-infected CD4+ T cells and monocytes contributes to immune dysfunction in chronic HIV infection and that TIGIT blockade could enhance antiviral effector cell function, in general, and especially against HIV [23].